Multilumen brachytherapy balloon catheter

Abstract
The disclosure describes a device for asymmetrical irradiation of a body cavity or site, such as after removal of tissue, e.g. biopsy or lumpectomy. The device includes an elongated tubular shaft having an inner lumen and a tubular wall with a plurality of lumens extending within the wall which are configured for receiving a radiation source. The distal portion of the tubular shaft is cut into a plurality of longitudinally separated wall segments with a lumen extending within at least one of the wall segments. A support member is positioned within the separated wall segments to support and position the wall segments in a desired configuration for brachytherapy. An expandable member such as an inflatable balloon is mounted on the distal shaft portion about the separated wall segments wall which when inflated secures the distal shaft portion within a desired intracorporeal site for brachytherapy treatment.
Description
FIELD OF THE INVENTION

This invention generally relates to devices and methods for treating tissue surrounding a body cavity, such as a site from which cancerous, pre-cancerous, or other tissue has been removed.


BACKGROUND OF THE INVENTION

In diagnosing and treating certain medical conditions, it is often desirable to perform a biopsy, in which a specimen or sample of tissue is removed for pathological examination, tests and analysis. A biopsy typically results in a biopsy cavity occupying the space formerly occupied by the tissue that was removed. As is known, obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant. Treatment of cancers identified by biopsy may include subsequent removal of tissue surrounding the biopsy site, leaving an enlarged cavity in the patient's body. Cancerous tissue is often treated by application of radiation, by chemotherapy, or by thermal treatment (e.g., local heating, cryogenic therapy, and other treatments to heat, cool, or freeze tissue).


Cancer treatment may be directed to a natural cavity, or to a cavity in a patient's body from which tissue has been removed, typically following removal of cancerous tissue during a biopsy or surgical procedure. For example, U.S. Pat. No. 6,923,754 to Lubock and U.S. patent application Ser. No. 10/849,410 to Lubock, the disclosures of which are all hereby incorporated by reference in their entireties, describe devices for implantation into a cavity resulting from the removal of cancerous tissue which can be used to deliver cancer treatments to surrounding tissue. One form of radiation treatment used to treat cancer near a body cavity remaining following removal of tissue is “brachytherapy” in which a source of radiation is placed near to the site to be treated.


Lubock above describes implantable devices for treating tissue surrounding a cavity left by surgical removal of cancerous or other tissue that includes an inflatable balloon constructed for placement in the cavity. Such devices may be used to apply one or more of radiation therapy, chemotherapy, and thermal therapy to the tissue surrounding the cavity from which the tissue was removed. The device may be configured to receive a solid or a liquid radiation source or both. Radiation treatment is applied to tissue adjacent the balloon of the device by placing radioactive material such as radioactive “seeds” in a delivery lumen within a distal treatment location. Such treatments may be repeated if desired. While the radiation source is typically a solid radiation source, a radiation source such as a miniature or micro-miniature x-ray tube may also be used (e.g. U.S. Pat. No. 6,319,188). The x-ray tubes are small, flexible and are believed to be maneuverable enough to reach the desired treatment location within a patient's body. The radiation source is to be removed following each treatment session, or remains in place as long as the balloon remains within the body cavity. These inflatable treatment delivery devices and systems are useful to treat cancer in tissue adjacent a body cavity.


However, radiation, chemotherapy, thermal treatment, and other cancer treatments often have deleterious effects on healthy tissue in addition to the desired effects on cancerous tissue. In such treatments, care must be taken to direct the maximum treatment effects to diseased tissue while minimizing its delivery or effects on healthy tissue. For example, radiation treatment may be most effective when only the portion of tissue requiring treatment receives the radiation and where surrounding healthy tissue is unaffected. Tissue cavities typically are not uniform or regular in their sizes and shapes, so that differences in dosages applied to different regions of surrounding tissue, including “hot spots” and regions of relatively low dosage, often result from radiation treatment.


Features of a treatment delivery device for treating tissue adjacent a body cavity, included in the Contura™ multilumen balloon catheter, have been disclosed in U.S. Pat. No. 6,923,754. This patent describes applying a partial-vacuum or suction to bring tissue towards an inflated balloon around a radiation source and allows for uniform application of radiation to tissue surrounding a body cavity. Additional features are described in copending application Ser. No. 11/593,784 and Ser. No. 11/593,789 relating to multilumen catheters which allow a greater degree of flexibility in asymmetric radiation source placement within the body cavity. However, some of these catheter constructions are complex and difficult to manufacture.


SUMMARY OF THE INVENTION

This invention is generally directed to a balloon catheter for treating a patient's body cavity or other intracorporeal site (hereinafter collectively referred to as a body cavity) and methods for such treatments. The invention is particularly suitable for treating tissue adjacent to a body cavity formed by the removal of tissue such as from a patient's breast in a lumpectomy.


More specifically, a device embodying features of the invention has an elongated shaft, a distal end, a distal shaft portion which has a treatment location and an inner lumen extending to the distal shaft portion. The elongated shaft has a shaft wall which at least in part defines an inner lumen and which has a plurality of lumens within the wall. The shaft wall in the distal shaft portion has a plurality of separated longitudinal wall segments having at least one lumen extending therein. A support member preferably extends within the distal shaft portion to support the separated longitudinal wall segments and preferably has a plurality of recesses configured to receive and support the separated longitudinal wall segments. The recesses of the support member preferably place the wall segments into a convex arcuate configuration away from a central longitudinal axis. The support member preferably has an inner lumen in fluid communication with the inner lumen defined by the shaft wall and preferably continues and is in fluid communication with the inner lumen of a tubular member within the inner lumen of the elongated shaft. The distal ends of the separated longitudinal wall segments are secured to the distal end of the support member or a distal tip of the elongated shaft with the separated wall segments in convex arcuate configurations away from the longitudinal axis. A distal tip at the distal end of the shaft preferably closes off the inner lumen of the support member and one or more of the lumens which extend within the wall segments.


The inner lumen of the elongated shaft within the treatment location and at least one of the lumens extending within the separated longitudinal wall segments are configured to receive a radiation source so as to treat tissue adjacent to the distal shaft portion. The lumens may be coated with a lubricous material or lined with a tubular member with an inner lumen having suitable lubricous properties (or a lubricous material thereon) to allow radiation sources to be readily advanced therein.


Preferably, the catheter has an enlarged or enlargeable cavity filling member at the treatment location, such as an inflatable which at least in part fills the body cavity. The cavity filling member is mounted onto the distal shaft portion surrounding the separated longitudinal wall segments so that when expanded will hold tissue lining the body cavity in a desired configuration. The proximal end of the balloon is secured proximal to the arcuate separated longitudinal segments and the distal end is secured to the distal ends of the separated longitudinal wall segments, the distal tip or both.


The distal tip of the catheter preferably has proximally extending plugs members to close off the lumens within the wall segments and preferably, the inner lumen of the support member.


One or more of the lumens in the shaft wall may be used to deliver inflation fluid to the interior of a balloon surrounding the distal shaft portion. One or more of the lumens in the shaft wall may be connected to a vacuum source to provide a vacuum to regions surrounding the distal shaft portion proximal and/or distal to the balloon through one or more vacuum ports therein, such as described in U.S. Pat. No. 6,923,754 and co-pending application Ser. No. 10/849,410 filed on May 19, 2004, both of which are assigned to the SenoRx, Inc., present assignee. Application of a vacuum within the inner lumen aspirates fluid in the cavity through one or more vacuum ports and the vacuum within the body cavity pulls tissue defining the cavity onto the exterior of the cavity filling member deployed within the cavity.


The arcuate configuration of the longitudinal wall segments allows for asymmetric deployment of radiation sources within the body cavity as described in co-pending application Ser. No. 11/593,784, and Ser. No. 11/593,789, both filed on Nov. 6, 2006, so as to be closer to a first portion of tissue surrounding the cavity than a second portion of tissue surrounding the cavity opposite the first tissue portion. This facilitates the radiation source to be offset or capable of being offset within the body cavity so that tissue of one portion of the cavity closer to the source receives more intense radiation treatment and tissue of the second portion further from the source receives less radiation.


The elongated shaft may also have one or more radiation shielding components designed to reduce or minimize damaging irradiation of healthy tissue surrounding the body cavity while treating nearby areas having diseased tissue with radiation emitted from the radiation source. The radiation shielding components include one or more radiation shields disposed about a delivery shaft containing the radiation source. Suitable radiation shielding components are describe in co-pending application Ser. No. 11/593,678 and 11/593,952, both filed on Nov. 6, 2006, both assigned to SenoRx, Inc. the present assignee.


A method for treating a body cavity or other intracorporeal site of a patient includes delivering a treatment agent such as a radiation source to a body cavity to treat the desired tissue while minimizing damaging irradiation of healthy tissues. More specifically, a method for treating a body cavity or intracorporeal site includes providing a device having an elongate shaft with a proximal end, a distal end, and a treatment location in a distal portion of the shaft. The method further includes providing a radiation source configured to be deposited in the treatment location and a radiation shielding component partially encircling the treatment location which is configured to control at least in part the emission of radiation emitted from the treatment location. The device is advanced within the patient until the treatment location of the device is deployed within the body cavity or site and the radiation source is positioned within the treatment location. The radiation shielding component is positioned to shield portions of the body cavity from radiation emitted from the radiation source.


A patient's skin is susceptible to damage from radiation delivered by isotopes (e.g. seeds) or x-ray catheters in a lumen of a radiation balloon catheter if the radiation source is too close to the skin. Generally, radiation treatments using a radiation balloon catheter is usually not performed on patients where the body cavity (e.g. from a lumpectomy) is less than 5 mm, sometimes less than 7 mm from the patient's skin. Additionally, over inflation of the balloon can thin and stretch the skin. The application of a vacuum to the body cavity can help by pulling the tissue to the balloon and increased cavity to skin surface distances would result. However, in some instances it would still be too thin to treat. The number of potential patient's which are suitable candidates for treatments with the present device is significantly increased due to reducing the potential for skin tissue damage.


The surface (inside or outside) of the balloon or within the balloon wall may be provided with indicator marks for location or orientation detection during the procedures. For example, dots or lines to help place balloon in appropriate position under CT, x-ray or fluoroscopy. The indicator marks may be radiopaque. Alternatively, or additionally, ultrasound indicators or MRI and direct visual indicators could be incorporated. The indicator marks may extend along the catheter shaft to help with placement of the catheter device during the treatment procedure and the orientation of the off-set lumen and shield.


One attractive additional feature for brachytherapy for breast lumpectomy sites is to provide heat to the tissue lining of the cavity either simultaneously with or sequentially to (before or after) irradiation. Suitable means to do this are described in U.S. Pat. No. 5,106,360 (Ishiwara et al.) wherein brachytherapy catheter is provided with heating electrical coils in the treatment region of the catheter. Other means such as inflation fluid at elevated temperatures may be employed. Generally, tissue temperature must be less than 100°, preferably less than 60° C. to avoid excess damage to surrounding health tissue.


The present invention provides a brachytherapy catheter device which is effective, easy to use and which is easy to manufacture. These and other advantages of the present invention are described in more detail in the following written description and the accompanying exemplary drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic perspective view, partially in section, of a brachytherapy device embodying features of the invention.



FIG. 2 is a transverse cross sectional view of the device shown in FIG. 1 taken along lines 2-2.



FIG. 3 is a transverse cross sectional view of the device shown in FIG. 1 taken along the lines 3-3.



FIG. 4 is a transverse cross sectional view of the device shown in FIG. 1 taken along the lines 4-4.



FIG. 5 is a transverse cross sectional view of the device shown in FIG. 1 taken along the lines 5-5.



FIG. 6 is a perspective view of the support member in the embodiment shown in FIG. 1.



FIG. 7 is a perspective view of the distal tip of the device shown in FIG. 1.



FIG. 8 is a longitudinal cross-sectional view of the distal tip shown in FIG. 7.



FIG. 9 is a perspective view of an alternative support member such as shown in FIG. 6 wherein the raised portions of the adjacent to the recess are provided with heating coils.





DETAILED DESCRIPTION OF THE INVENTION

The present invention is directed to devices and methods for treatment of a patient's body cavity, particularly to deliver asymmetrical radiation into a body cavity such as a cavity left after removal of tissue from the site. While the detailed description is directed to a device configured for treating a patient' breast after tissue removal such as in a lumpectomy, other body sites may also be treated with the device.



FIGS. 1-8 illustrate a brachytherapy catheter device 10 embodying features of the invention which has an elongated shaft 11, a distal tip 12, a treatment location 13 in a distal shaft portion 14 proximal to the distal tip. The device 10 has a balloon 15 on the distal shaft portion 14 which surrounds the treatment location 13. A hub 16 is mounted on the proximal end of the shaft 11 which has an inflation line 17 with leur connection 18, a vacuum line 19 with a leur connection 20 and four outer delivery tubes 21, 22, 23, 24 for delivery of a radiation source through the lumens thereof to the treatment location 13 off set from a centrally location longitudinal axis 25 to provide asymmetrical radiation of tissue surrounding the balloon 15. The leur connections 18 and 20 are provided with threaded caps 26 and 27 respectively to close off the connections. Each of the delivery tubes has a removable cap 28, 29, 30, and 31 respectively to close of the delivery tubes until use. A centrally located delivery tube 32 is provided for radiation source delivery along the central longitudinal axis within the treatment location which also has a removable cap 33.


The hub 16 has a ridge 34 which is aligned with marker line 35 to provide the physician or other professional the orientation of the treatment location 13. The elongated shaft 11 may also be provided with depth markings to help in the placement of the balloon 15 within the cavity.


As shown best in FIG. 2, the elongated shaft 11 has eight lumens, four lumens 36, 37, 38 and 39 equally spaced about the longitudinal axis 25 for radiation source delivery as described above and four equally spaced additional lumens 40, 41, 42 and 43, lumen 40 for vacuum application and lumen 42 for inflation fluid delivery to the interior of balloon 15. Lumens 41 and 44 are not used in this embodiment, but may be used for a variety of functions. A proximal vacuum port 44 is provided in fluid communication with lumen 40 and distal vacuum port 45 (shown best in FIGS. 5 and 7-8) is provided in the distal tip 12 which is in fluid communication with lumen 40 through the annular space 46 between the central delivery tube 32 and center lumen 47 of support member 48 shown in FIGS. 2-4. The support member 48, which is best shown in FIG. 6.


As shown in FIGS. 1, 3 and 4, the distal shaft portion 14 is split into four separate longitudinal wall segments 49, 50, 51 and 52, with each wall segment having one of the radiation source lumens 36-39 and being disposed within one of the recesses 53-56 in the exterior surface of support member 48. Recesses 55-56 are not shown in FIG. 6 but are on the opposite side of support member 48. The longitudinal wall segments 49-52 are slit through the lumens 40-43 as best shown in FIGS. 3-5. Lumens 40-43 are plugged off proximal to the split of the wall segments 49-52. This wall segment structure facilitates the manufacture of the catheter. The elongated shaft may be extruded with all eight lumens 36-43 in place and the distal shaft portion 14 is segmented by cutting through lumens 40-43 by a cutting blade or other suitable cutting element. The support member 48 may be slid over the central delivery tube 32 with the proximal end of the support member secured within the central lumen of the shaft 11. The free ends of the slit wall segments 49-52 are secured to the distal end of the support member 48. The balloon 15 may then be secured to the shaft 11 with wound sutures 57 and 58 further securing the ends of the balloon to the shaft. The outer delivery tubes 21-24 may extend through lumens 36-39 to the distal ends of the wall segments 49-52. Inflation line 17 and vacuum line 19 may likewise extend through lumens 40 and 41 to a location (not shown) proximal to the split of the wall segments 49-52.


As best shown in FIGS. 5, 7 and 8, the distal tip 12 has the distal vacuum port 45 which is in fluid communication with the annular space 46 between central delivery tube 32 and lumen 47 of support member 48. The distal tip 12 is provided with outer source lumen plugs 60-63 for plugging lumens 36-39 and center source lumen plug 64 for plugging the distal end of central tube 32.


The brachytherapy catheter device 10 is readily manufactured. The elongated shaft 11 is extruded, preferably with the lumens 36-43 within the wall and the central lumen 46. The distal shaft portion 14 is cut by a suitable cutting member such as a razor or knife like member to form the plurality of separated longitudinal wall segments 49-52. The support member 48 is preferably machined from an extruded tubular polymeric product to form the recesses 53-56 and overall shape and centrally placed within the separated longitudinal wall segments. A tubular member 32 is positioned within the inner lumen of the elongated shaft 11 and may continue to the distal end of the shaft through the inner lumen of the support member 48. The distal tip 12 is secured to the distal end of the shaft 11 and support member 48 with plug members 60-63 inserted into the lumens within the wall segments 49-52 and central plug member 64 within the lumen of the centrally disposed tubular member 32. The distal tip 12 is preferably preformed with the vacuum ports 45. The distal ends of the separated longitudinal wall segments are secured to the distal end of the device, preferably to the distal end of the support member. The balloon 15 is mounted about the wall segments 49-52 and support member 48 with the distal end of the balloon secured to the distal end of the wall segments and support member and the proximal end of the balloon is secured to the elongated shaft proximal to the separated longitudinal wall segments. Preferably, strands or sutures are wrapped around each of the mounted ends of the balloon 15 to provide further support to the ends. The proximal end of the device 10 is similar to the brachytherapy devices previously described in copending application Ser. Nos. 11/593,784 and 11/593,789 previously referred to herein.


A body cavity within a patient may be treated with the device 10 by inserting the distal shaft portion 13 into the desired body cavity, inflating the balloon 15 with inflation fluid to secure the device within the patient and applying a vacuum to either the distal or proximal vacuum ports or both to conform the tissue lining the cavity to the exterior of balloon 15. A radiation source is advanced through one or more of the source delivery lumens until the radiation source is properly positioned within the treatment location 13 (or prepositioned therein). The radiation source (not shown) is maintained at the treatment location 13 for a prescribe period of time, usually less than 30 minutes and typically a few (5-10) minutes. The radiation source may be placed at several places within the treatment location with in one or multiple source lumens. At the end of the treatment time, the radiation source may be removed from device 10 or the entire device may be withdrawn from the patient. Preferably, the device is left in place so that further radiation treatments may be performed.


The radiation source for the brachytherapy device 10 can include a solid, liquid or slurried radiation source. Suitable liquid radiation sources include, for example, a liquid containing a radioactive iodine isotope (e.g., I125 or I131), a slurry of a solid isotope, for example, 198Au or 169Yb, or a gel containing a radioactive isotope. Liquid radiation sources are also commercially available (e.g., Iotrex®, Proxima Therapeutics, Inc., Alpharetta, Ga.). The solid radiation source may be a radioactive microsphere available from 3M Company of St. Paul, Minn. A micro miniature x-ray source may also be utilized. The radiation source may be either preloaded into the device 10 at the time of manufacture or may be loaded into the device 10 before or after placement into a body cavity or other site of a patient. Solid radionuclides suitable for use with a device 10 embodying features of the present invention are currently generally available as brachytherapy radiation sources (e.g., I-Plant™ Med-Tec, Orange City, Iowa.). Radiation may also be delivered by a device such as the x-ray tube of U.S. Pat. No. 6,319,188. The x-ray tubes are small, flexible and are believed to be capable of being maneuverable enough to reach the desired location within a patient's body.


The source delivery lumens of brachytherapy device 10 having features of the invention can be provided with a lubricious coating, such as a hydrophilic material. The lubricious coating preferably is applied to the elongate shaft 12 or to the cavity filling member, if one is present or both to reduce sticking and friction during insertion of a device 10. Hydrophilic coatings such as those provided by AST, Surmodics, TUA Systems, Hydromer, or STS Biopolymers are suitable.


A device 10 having features of the invention may also include an antimicrobial coating that covers all or a portion of the device 10 to minimize the risk of introducing of an infection during extended treatments. The antimicrobial coating preferably is comprised of silver ions impregnated into a hydrophilic carrier. Alternatively the silver ions are implanted onto the surface of the device 10 by ion beam deposition. The antimicrobial coating preferably is comprised of an antiseptic or disinfectant such as chlorhexadiene, benzyl chloride or other suitable biocompatible antimicrobial materials impregnated into hydrophilic coatings. Antimicrobial coatings such as those provided by Spire, AST, Algon, Surfacine, Ion Fusion, or Bacterin International would be suitable. Alternatively a cuff member covered with the antimicrobial coating is provided on the elongated shaft of the delivery device 10 at the point where the device 10 enters the skin.



FIG. 9 illustrates a modified support member 48 which is provided with a heating coil 70 to raise the temperature of tissue in the cavity lining either simultaneously with or sequentially to irradiation of the cavity lining as previously described. While FIG. 9 depicts a heating 70 on one raised portion of the support member 48, a heating element may be provided on a plurality of raised portions of the support member. Preferably, the heating coils are powered by RF energy and are connected to a suitable high frequency generator. Voltage, current, frequency and duty factor may be adjusted to provide a suitable thermal treatment to tissue lining the cavity to augment the irradiation thereof. Other means may include heating the inflation fluid within the balloon 15. The heating of the inflation fluid may be exterior to the device 10.


While particular forms of the invention have been illustrated and described herein, it will be apparent that various modifications and improvements can be made to the invention. Additional details of the brachytherapy catheter devices may be found in the patents and applications incorporated herein. To the extent not otherwise disclosed herein, materials and structure may be of conventional design.


Moreover, individual features of embodiments of the invention may be shown in some drawings and not in others, but those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of another embodiment. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention be defined by the scope of the appended claims as broadly as the prior art will permit.


Terms such as “element”, “member”, “component”, “device”, “means”, “portion”, “section”, “steps” and words of similar import when used herein shall not be construed as invoking the provisions of 35 U.S.C §112(6) unless the following claims expressly use the terms “means for” or “step for” followed by a particular function without reference to a specific structure or a specific action. All patents and all patent applications referred to above are hereby incorporated by reference in their entirety.

Claims
  • 1. A brachytherapy device for irradiating tissue surrounding a body cavity within a patient, comprising: an elongated shaft having an inner lumen, a wall at least in part defining the inner lumen, a plurality of lumens within the wall and a central longitudinal axis;a distal shaft portion having a treatment location and a plurality of longitudinally separated wall segments, with at least one of the wall segments having a lumen extending therein configured to receive a radiation source; anda support member extending within the distal shaft portion to support the plurality of longitudinally separated wall segments in off-set positions,wherein the support member has an inner lumen which is in fluid communication with the inner lumen defined by the wall of the elongated shaft and which is configured to receive the radiation source,wherein the inner lumen of the support member has a tubular member therein which has a lumen that receives the radiation source, andwherein the inner lumen of the shaft has a tubular member therein which has a lumen in fluid communication with the lumen of the tubular member within the support member which directs the radiation source to the lumen of the tubular member within the support member.
  • 2. The device of claim 1 wherein at least one wall segment is off-set from the central longitudinal axis so that the radiation source provides asymmetrical irradiation to the tissue surrounding the body cavity.
  • 3. The device of claim 1 wherein the support member has a plurality of recesses configured to receive the wall segments.
  • 4. The device of claim 3 wherein the recesses of the support member are configured to support the wall segments in arcuate shapes.
  • 5. The device of claim 1 wherein the elongated shaft has a distal tip and each of the wall segments has a distal end, the distal tip being configured to engage the distal end of each of the wall segments.
  • 6. The device of claim 5 wherein the distal tip is configured to seal at least one lumen extending within a wall segment of the plurality of longitudinally separated wall segments.
  • 7. The device of claim 5 wherein the distal tip is configured to seal the lumen of the tubular member that receives the radiation source.
  • 8. The device of claim 2 wherein the radiation source irradiates a first portion of the tissue surrounding the body cavity more intensely than an opposing second portion of tissue of the body cavity due to being closer to the first portion of tissue than the second portion of tissue as a result of the off-set.
  • 9. The device of claim 1 wherein the distal shaft portion has an expandable member surrounding the treatment location configured to engage tissue of the body cavity and which has a contracted configuration and an expanded configuration spaced from at least one of the wall segments in the treatment location.
  • 10. The device of claim 9 wherein the expandable member is a balloon with an interior configured to receive inflation fluid.
  • 11. The device of claim 10 wherein at least one lumen of the plurality of lumens within the wall of the shaft at a location proximal to the distal shaft portion is configured to be in fluid communication with a source of inflation fluid and the interior of the balloon.
  • 12. The device of claim 1 wherein the elongated shaft has at least one vacuum port which is in fluid communication with a lumen within the wall of the shaft.
  • 13. The device of claim 1 wherein the elongated shaft has a distal tip and wherein the distal tip has at least one proximally extending plug element which is configured to be inserted into a lumen within a wall segment.
  • 14. The device of claim 1 wherein a heating element is provided within the treatment location configured to provide heat to tissue surrounding the cavity simultaneously with or sequentially to irradiation by the radiation source.
  • 15. The device of claim 14 wherein the heating element is configured for connection to a high frequency electrical source.
  • 16. A brachytherapy device for irradiating tissue surrounding a body cavity within a patient, comprising: an elongated shaft having an inner lumen, a wall at least in part defining the inner lumen, a plurality of lumens within the wall and a central longitudinal axis; anda distal shaft portion having a treatment location and a plurality of longitudinally separated wall segments, with at least one of the wall segments having a lumen extending therein configured to receive a radiation source;a balloon coupled to the elongated shaft, the balloon being configured to surround the treatment location; anda heating element provided within the treatment location configured to provide heat to tissue surrounding the cavity simultaneously with, or sequentially to, irradiation by the radiation source, andwherein the heating element heats inflation fluid within the balloon surrounding the treatment location.
  • 17. The device of claim 16, comprising a support member extending within the distal shaft portion to support the plurality of longitudinally separated wall segments in off-set positions, wherein the heating element is provided with the support member.
  • 18. A brachytherapy device for irradiating tissue surrounding a body cavity within a patient, comprising: an elongated shaft having an inner lumen, a wall at least in part defining the inner lumen, a plurality of lumens within the wall and a central longitudinal axis; anda distal shaft portion having a treatment location and a plurality of longitudinally separated wall segments, with at least one of the wall segments having a lumen extending therein configured to receive a radiation source,wherein the distal shaft portion has an expandable member surrounding the treatment location configured to engage tissue of the body cavity and which has a contracted configuration and an expanded configuration spaced from at least one of the wall segments in the treatment location,wherein the expandable member is a balloon with an interior configured to receive inflation fluid,wherein at least one lumen within the wall of the shaft proximal to the distal shaft portion is configured to be in fluid communication with a source of inflation fluid and the interior of the balloon, andwherein the source of inflation fluid is configured to heat the inflation fluid before delivery to the at least one lumen within the wall of the shaft in fluid communication with the source of inflation fluid.
RELATED APPLICATIONS

This application is related to provisional application Ser. No. 61/062,179, filed on Jan. 24, 2008, which is incorporated herein in its entirety and which is relied upon for priority.

US Referenced Citations (156)
Number Name Date Kind
3324847 Zoumboulis Jun 1967 A
3872856 Clayton Mar 1975 A
3975350 Hudgin et al. Aug 1976 A
4119094 Micklus et al. Oct 1978 A
4454106 Gansow et al. Jun 1984 A
4690677 Erb Sep 1987 A
4763642 Horowitz Aug 1988 A
4929470 Rittenhouse et al. May 1990 A
4998930 Lundahl Mar 1991 A
5059166 Fischell et al. Oct 1991 A
5106360 Ishiwara et al. Apr 1992 A
5167622 Muto Dec 1992 A
5199939 Dake et al. Apr 1993 A
5227969 Waggener et al. Jul 1993 A
5259847 Trambert Nov 1993 A
5302168 Hess Apr 1994 A
5312356 Engelson et al. May 1994 A
5314518 Ito et al. May 1994 A
5342305 Shonk Aug 1994 A
5381504 Novack et al. Jan 1995 A
5411466 Hess May 1995 A
5417687 Nardella et al. May 1995 A
5428658 Oettinger et al. Jun 1995 A
5429582 Williams Jul 1995 A
5503613 Weinberger Apr 1996 A
5535817 Dunne Jul 1996 A
5566221 Smith et al. Oct 1996 A
5603991 Kupiecki et al. Feb 1997 A
5611767 Williams Mar 1997 A
5616114 Thorton et al. Apr 1997 A
5621780 Smith et al. Apr 1997 A
5653683 D'Andrea Aug 1997 A
5662580 Bradshaw et al. Sep 1997 A
5704926 Sutton Jan 1998 A
5720717 D'Andrea Feb 1998 A
5759173 Preissman et al. Jun 1998 A
5782742 Crocker et al. Jul 1998 A
5820594 Fontirroche et al. Oct 1998 A
5820717 Siegenthaler Oct 1998 A
5863285 Coletti Jan 1999 A
5908406 Ostapchenko et al. Jun 1999 A
5913813 Williams et al. Jun 1999 A
5916143 Apple et al. Jun 1999 A
5919473 Elkhoury Jul 1999 A
5924973 Weinberger Jul 1999 A
5931774 Williams et al. Aug 1999 A
5935098 Blaisdell et al. Aug 1999 A
5993972 Reich et al. Nov 1999 A
6022308 Williams Feb 2000 A
6033357 Ciezki et al. Mar 2000 A
6036631 McGrath et al. Mar 2000 A
6083148 Williams Jul 2000 A
6086970 Ren Jul 2000 A
6093142 Ciamacco, Jr. Jul 2000 A
6095966 Chornenky et al. Aug 2000 A
6143013 Samson et al. Nov 2000 A
6200257 Winkler Mar 2001 B1
6217565 Cohen Apr 2001 B1
6251059 Apple et al. Jun 2001 B1
6256529 Holupka et al. Jul 2001 B1
6282142 Miyawaki Aug 2001 B1
6378137 Hassan et al. Apr 2002 B1
6390967 Forman et al. May 2002 B1
6390968 Harmon May 2002 B1
6390992 Morris et al. May 2002 B1
6398708 Hastings et al. Jun 2002 B1
6413203 Sahatjian Jul 2002 B1
6413204 Winkler et al. Jul 2002 B1
6416492 Nielson Jul 2002 B1
6458069 Tam et al. Oct 2002 B1
6482142 Winkler et al. Nov 2002 B1
6512942 Burdette et al. Jan 2003 B1
6527693 Munro, III et al. Mar 2003 B2
6540655 Chin et al. Apr 2003 B1
6605030 Weinberger Aug 2003 B2
6610013 Fenster et al. Aug 2003 B1
6615070 Lee Sep 2003 B2
6673006 Winkler Jan 2004 B2
6706014 Banik et al. Mar 2004 B2
6723052 Mills Apr 2004 B2
6746392 Stiger et al. Jun 2004 B2
6752752 Geitz Jun 2004 B2
6770058 Liprie Aug 2004 B1
6913600 Valley et al. Jul 2005 B2
6923754 Lubock Aug 2005 B2
6955641 Lubock Oct 2005 B2
6983754 Anderson et al. Jan 2006 B1
7098463 Adamovics Aug 2006 B2
7107089 Lee Sep 2006 B2
7171255 Holupka et al. Jan 2007 B2
7201715 Burdette et al. Apr 2007 B2
7214178 Lubock May 2007 B2
7322929 Lovoi Jan 2008 B2
7404791 Lunares et al. Jul 2008 B2
7407476 Lubock et al. Aug 2008 B2
7413539 Lubock et al. Aug 2008 B2
7465268 Lubock et al. Dec 2008 B2
7476235 Diederich et al. Jan 2009 B2
7497819 White et al. Mar 2009 B2
7497820 White et al. Mar 2009 B2
7513861 Klein et al. Apr 2009 B2
7783006 Stewart et al. Aug 2010 B2
7885382 Stewart et al. Feb 2011 B2
7887476 Hermann et al. Feb 2011 B2
20010016725 Valley et al. Aug 2001 A1
20010049464 Ganz Dec 2001 A1
20010051669 Mcghee Dec 2001 A1
20020045893 Lane et al. Apr 2002 A1
20020055666 Hunter et al. May 2002 A1
20020095114 Palasis Jul 2002 A1
20020177804 Saab Nov 2002 A1
20030144570 Hunter et al. Jul 2003 A1
20040039437 Sparer et al. Feb 2004 A1
20040054366 Davison et al. Mar 2004 A1
20040087827 Lubock May 2004 A1
20040116767 Lebovic et al. Jun 2004 A1
20040215048 Lubock Oct 2004 A1
20040260142 Lovoi Dec 2004 A1
20050061771 Murphy Mar 2005 A1
20050080313 Stewart et al. Apr 2005 A1
20050124843 Singh Jun 2005 A1
20050182286 Lubock Aug 2005 A1
20050240073 Apffelstaedt et al. Oct 2005 A1
20050240074 Lubock Oct 2005 A1
20050277577 Hunter et al. Dec 2005 A1
20060020156 Shukla Jan 2006 A1
20060020256 Bell et al. Jan 2006 A1
20060100475 White et al. May 2006 A1
20060116546 Eng Jun 2006 A1
20060136051 Furst et al. Jun 2006 A1
20060167416 Mathis et al. Jul 2006 A1
20060173233 Lovoi Aug 2006 A1
20060173235 Lim et al. Aug 2006 A1
20060205992 Lubock et al. Sep 2006 A1
20070005003 Patterson et al. Jan 2007 A1
20070055144 Neustadter et al. Mar 2007 A1
20070106108 Hermann et al. May 2007 A1
20070167666 Lubock et al. Jul 2007 A1
20070167668 White et al. Jul 2007 A1
20070191667 Lubock et al. Aug 2007 A1
20070270627 Cutrer et al. Nov 2007 A1
20080057298 Finley Mar 2008 A1
20080064915 Lubock Mar 2008 A1
20080091055 Nguyen et al. Apr 2008 A1
20080188705 Lubock et al. Aug 2008 A1
20080221444 Ritchie et al. Sep 2008 A1
20080228025 Quick Sep 2008 A1
20080228150 Jones et al. Sep 2008 A1
20080281142 Lubock et al. Nov 2008 A1
20080281143 Lubock et al. Nov 2008 A1
20080287801 Magnin et al. Nov 2008 A1
20090030259 Quick Jan 2009 A1
20090124845 Lubock et al. May 2009 A1
20090171157 Diederich et al. Jul 2009 A1
20100010287 Lubock Jan 2010 A1
20100048979 Jones et al. Feb 2010 A1
Foreign Referenced Citations (31)
Number Date Country
0 536 440 Oct 1991 EP
0 642 766 Mar 1995 EP
0 693 293 Jan 1996 EP
0 719 571 Jul 1996 EP
0 853 957 Jul 1998 EP
0 867 200 Sep 1998 EP
1 051 990 Nov 2000 EP
1070514 Jan 2001 EP
1 402 922 Mar 2004 EP
1541188 Jun 2005 EP
1 618 924 Jan 2006 EP
10137250 May 1998 JP
2001 120561 May 2001 JP
2177350 Dec 2001 RU
WO 9520241 Jul 1995 WO
9712540 Apr 1997 WO
WO 9745053 Dec 1997 WO
9815315 Apr 1998 WO
9934869 Jul 1999 WO
WO 0114011 Mar 2001 WO
WO 0143826 Jun 2001 WO
WO 0158346 Aug 2001 WO
WO 0209599 Feb 2002 WO
WO 02069862 Sep 2002 WO
WO 2004043531 May 2004 WO
WO 2005037363 Apr 2005 WO
2005039655 May 2005 WO
WO 2005039665 May 2005 WO
WO 2005067442 Jul 2005 WO
WO 2007027831 Mar 2007 WO
WO 2007143560 Dec 2007 WO
Non-Patent Literature Citations (63)
Entry
Abstracts of the 11th International Conference on Brain tumor Research and Therapy Oct. 31-Nov. 3, 1995, Silverado Country Club and Resort, Napa, California, Journal of Neuro-Oncology 28:72, 1996.
Johannesen, T.B. et al, “Intracavity Fractioned Balloon Brachytherapy in Glioblastoma”, Acta Neurochir (Wien) (1999) 141: 127-133.
U.S. Appl. No. 11/981,182, filed Oct. 31, 2007, Jones et al.
U.S. Appl. No. 11/980,976, filed Oct. 31, 2007, Jones et al.
U.S. Appl. No. 12/321,244, filed Jan. 20, 2009, Acosta et al.
International Search Report of PCT/US2009/000402 mailed Apr. 15, 2009.
Paul V. Harper, “Some Therapeutic Applications of Radioisotopes”, Journal of the Mississippi State Medical Association, Oct. 1966, vol. VII, pp. 526-533.
“Variable shield for radiation-therapy source wire and centering catheter”, Research disclosure, Mason Publications, Hampshire, GB, vol. 438, No. 48, Oct. 2000, XP007126916.
Gregory K. Edmundson et al., “Dosimetric Charateristics of the Mammosite RTS, a New Breast Brachytherapy Applicator”, Int. J. Radiation Oncology Biol. Phys, vol. 52, No. 4, pp. 1132-1139, 2002.
Melvin A. Astrahan, PhD et al., “Optimization of Mammosite therapy”, Int. J. Radiation Oncology Biol. Phys, vol. 58, No. 1, pp. 220-232, 2004.
Philip H. Gutin, et al., “A coaxial catheter system for after loading radioactive sources for the interstitial irradiation of brain tumors”, J. Neurosur, vol. 56, pp. 734-735, 1982.
R. D. Ashpole et al., “A New Technique of Brachytherapy for Malignant Gliomas with Caesium-137; A New Method Utilizinga Remote Afterloading system”, Clinical Oncology, (1990).
Tanderup, et al, “Multi-Channel Intracavitary Vaginal Brachytherapy Using Three-Dimensional Optimization of Source Geometry”, Radiation & Oncology Journal of the European Society for Therapeutic Radiology and Oncology, 2004, pp. 81-85, Radiotherapy and Oncology 70 (2004), Elsevier Ireland Ltd.
Devic, et al., “Advantages of Inflatable Multichannel Endorectal Applicator in The Neo-Adjuvant Treatment of Patients With Locally Advanced Rectal Cancer With HDR Brachytherapy”, Journal of Applied Clinical Medical Physics, Spring 2005, pp. 44-49, vol. 6, No. 2.
Symon, et al. “Individual Fraction Optimization vs. First Fraction Optimization for Multichannel Applicator Vaginal Cuff High-Dose-Rate Brachytherapy”, pp. 211-215, Brachytherapy 5 (2006), Elsevier.
Friedman, M, et al., “A New Technic for the Radium Treatment of Carcinoma of the Bladder”, Presented at the Thirty-fourth Annual Meeting of the Radiological Society of North America, Dec. 5-10, 1948, pp. 342-362.
Walton, R. J., “Therapeutic Uses of Radioactive Isotopes in The Royal Cancer Hospital”, The British Journal of Radiology, 1950, pp. 559-599, William Heinemann, Publisher.
Low-Beer, B. V. A., “Radioisotope Therapy”, “The Clinical Use of Radioactive Isotopes” 1950, pp. 284-349, Charles C. Thomas, Publisher, Springfield, Illinois, U.S.A., See pp. 343-349.
Low-Beer, B. V. A., “The Therapeutic Use of Radioactive Isotopes”, “Practical Therapeutics”, Dec. 1954, pp. 69-87, vol. X, No. 6.
Muller, J. H., “Radiotherapy of Bladder Cancer by Means of Rubber Balloons Filled in Situ With solutions of a Radioactive Isotope (Co60)”, Cancer, A Journal of the American Cancer Society, Jul.-Aug. 1955, pp. 1035-1043, vol. 8, No. 4, J. B. Lippincott Company, Philidelphia.
Friedman, M, et al., “Irradiation of Carcinoma of The Bladder by a Central Intracavitary Radium or Cobalt 60 Source (The Walter Reed Technique)”, Presented at the Annual Meeting of the American Radium Society, 1955, pp. 6-31.
Hewitt, C. B., et al., “Update on Intracavitary Radiation in the Treatment of Bladder Tumors”, The Journal of Urology; Official Journal of The American Urological Association, Inc., 1981, pp. 323-325, vol. 126 September, The Williams & Wilkins Co.
Hieshima,G. B., et al. “A Detachable Balloon for Therapeutic Transcatheter Occlusions 1”, Technical Notes, Jan. 1981, pp. 227-228, vol. 138.
Russel, A. H., et al, “Intracavitary Irradiation for Carcinoma of the Urinary Bladder: Rationale, Technique, and Preliminary Results”, Int. J. Radiation Oncology. Phys,. 1984, pp. 215-219, vol. 10, Pergamon Press Ltd.
Yin, W., “Brachtherapy of Carcinoma of the Esophagus in China, 1970-1974 and 1982-1984”, Brachytherapy HDR and LDR, May 4-6, 1989, pp. 52-56.
Kaufman, N., “Remote Afterloading Intraluminal Brachytherapy in The Treatment of Rectal, Rectosigmoid, and Anal Cancer: A Feasibility Study”, International Journal of Radiation Oncology, Biology, Physics, Sep. 1989, pp. 663-668, vol. 17, Issue 3, Pergamon Press plc.
Wolf, C. D., et al., “A Unique Nasopharynx Brachytherapy Technique”, Official Journal of the American Association of Medical Dosimetrists, 1990, pp. 133-136, vol. 15, Issue No. 3., Pergamon Press.
Fowler, J. F., “Brief Summary of Radiobiological Principles in Fractionated Radiotherapy”, Seminars in Radiation Oncology, Jan. 1992, pp. 16-21, vol. 2, No. 1, W. B. Saunders Company.
Nag, S, “Modern Techniques of Radiation Therapy for Endometrial Cancer”, Clinical Obstetrics and Gynecology, Sep. 1996, pp. 728-744, vol. 39, No. 3, Lippincott-Raven Publishers.
Pernot, M., “Combined Surgery and Brachytherapy in the Treatment of Some Cancers of the Bladder (Partial Cystectomy and Interstitial Iridium-192)”, Radiotherapy & Oncology, 1996, pp. 115-120, Elsevier Science Ireland Ltd.
Micheletti, E., et al., “High-Dose-Rate Brachytherapy for Poor-Prognosis, High-Grade Glioma: (Phase II) Preliminary Results”, Tumori, 1996, pp. 339-344.
Nag, S., et al., “Perineal Template Interstitial Barchytherapy Salvage for Recurrent Endometrial Adenocarcinoma Metastatic to the Vagina”, Necologic Oncology 66, 1997, pp. 16-19, Article No. GO974722, Academic Press.
Nag, S., et al., “Remote Controlled High Dose Rate Brachytherapy”, Critical Reviews in Oncology/Hematology 22, 1996, pp. 127-150, Elsevier Science Ireland Ltd.
Sylvester, J., et al., “Interstitial Implantation Techniques in Prostate Cancer” Journal of Surgical Oncology 1997; 66: 65-75, Wiley-Liss, Inc.
Tan, L. T., et al., Radical Radiotherapy for Carcinoma of the Uterine Cervix Using External Beam Radiotherapy and A Single Line Source Brachytherapy Technique: The Clatterbridge Technique, The British Journal of Radiology, 70, date Dec. 1997, pp. 1252-1258.
Kuettel, M. R., et al., “Treatment of Female Urethral Carcinoma in Medically Inoperable Patients Using External Beam Irradiation and High Dose Rate Intracavitary Brachytherapy” The Journal of Urology, May 1997, pp. 1669-1671, vol. 157, The American Urological Association, Inc.
Slevin, N. J., et al., “Intracavitary Radiotherapy Boosting for Nasopharynx Cancer” The British Journal of Radiology, 70, Apr. 1997, pp. 412-414.
Sneed, P, K., et al., Interstitial Brachytherapy Procedures for Brain Tumors, Seminars in Surgical Oncology 1997; 13: 157-166, Wiley-Liss, Inc.
Dempsey, J. F., et al., “Dosimetric Properties of a Novel Brachytherapy Balloon Applicator for The Treatment of Malignant Brain-Tumor Resection-Cavity Margins” Int. J. Radiation Oncology Biol. Phys., May 1998, pp. 421-429, vol. 42, No. 2, Elsevier.
Kolotas, C., et al., “CT Guided Interstitial High Dose Rate Brachytherapy for Recurrent Malignant Gliomas”, The British Journal of Radiology, 72, (1999), pp. 805-808.
Demanes, D, J., et al., “The Use and Advantages of a Multichannel Vaginal Cylinder in High-Dose-Rate Brachytherapy”, Int. J. Radiation Oncology Biol. Phys., (1999), pp. 211-219, vol. 44, No. 1, Elsevier Science Inc.
Debicki, M. P., et al., “Localized Current Field Hyperthermia in Carcinoma of The Cervix: 3-D Computer Simulation of SAR Distribution”, International Journal of Hyperthermia, 1999, pp. 427-440, vol. 15, No. 5.
Garipagaoglu, M, et al., “Geometric and Dosimetric Variations of ICRU Bladder and Rectum Reference Points in Vaginal Cuff Brachytherapy Using Ovoids”, Int. J. Radiation Oncology Biol. Phys.. 2004, pp. 1607-1615, Elsevier Inc.
Bowsher, W. G., et al., “Update on Urology-Prostate Cancer, 4-Treatment of Local Disease”, European Journal of Surgical Oncology, 1995 pp. 679-682, vol. 21, No. 6.
Voung, T, et al., “High-Dose-Rate Endorectal Brachytherapy in the Treatment of Loacally Advanced Rectal Carcinoma: Technical Aspects”, Brachytherapy 4, 2005, pp. 230-235, Elsevier.
Harada, T, et al., “Transcystoscopic Intracavitary irradiation for Carcinoma of The Bladder: Technique and Preliminary Clinical Results”, The Journal of Urology, Oct. 1987, pp. 771-774, vol. 138, No. 4, The Williams & Wilkins Co.
Hall, J. W., et al., “Histologic Changes in Squamous-Cell Carcinoma of the Mouth and Oropharynx Produced by Fractionated External Roentgen Irradiation”, Radiological Society of North America, 1948, pp. 318-350, 50/3/MAR.
Hine, G. J., et al., “Isodose Measurements of Linear Radium Sources in Air and Water by Means of an Automatic Isodose Recorder”,The American Journal of Roentgenology and Radium Therapy, 1950, pp. 989-998, vol. 64, No. 6, The Societies.
Walton, R. J., et al., Radioactive Solution (24Na and 82 Br) in the Treatment of Carcinoma of The Bladder:, British Medical Bulletin, 1952, pp. 158-165, Medical Dept., The British Council.
Marshall V. F., et al., “Current Clinical Problems Regarding Bladder Tumors”, Symposium on Bladder Tumors, 1956, pp. 543-550, 9/3/May-Jun., J. B. Lippincott Co, Etc.
Hewitt, C. B., et al., “Intracavitary Radiation in the Treatment of Bladder Tumors”, The Journal of Urology, vol. 107, Apr. 1972, pp. 603-606, The Williams & Wilkins Co.
Rotman, M., et al., “The Intracavitary Applicator in Relation to Complications of Pelvic Radiation—The Ernst System”, Int. J. Radiation Oncology Biol. Phys., 1978, pp. 951-956, vol. 4, Pergamon Press Inc.
Nag, S., et al., “The Future of High Dose Rate Brachytherapy”, High Dose Rate Brachytherapy: A Textbook, 1994, pp. 447-453, Futura Publishing Company, Inc. , Armonk, New York 10504.
Wang, C. C., “Carcinoma of the Nasopharynx”, Radiation Therapy of Head and Neck Neoplasms, 1997, pp. 257-280, Chapter 10, Wiley-Liss, Inc.
Gaspar, L. E., et al., “Esophageal Brachytherapy”, Principles and Practice of Brachytherapy, 1997, pp. 305-321, Futrua Publishing Company, Inc., Armouk, New York.
Vicini, F. A., et al, “Dose-Volume Analysis for Quality Assurance of Interstitial Brachytherapy for Breast Cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 45, 1999, pp. 803-810, Elsevier Science Inc.
Akagi, Y, et al., “Optimum Fractionation for High-Dose-Rate Endoesophageal Brachytherapy Following External Irradiation of Early State Esophageal Cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 43, 1999, pp. 525-530, Elsevier Science, Inc.
Xu, Z., et al., “Calculation of Dose Distribution Near an Innovative Concentric Balloon Catheter for Endovascular Brachytherapy”, Cardiovascular Radiation Medicine 2, 2000, pp. 26-31, Elsevier Science Inc.
Stubbs, J. B., et al., “Preclinical Evaluation of a Novel Device for Delivering Brachytherapy to the Margins of Resected Brain Tumor Cavities”, J. Neurosurg 96, Feb. 2002, pp. 335-343, vol. 96.
Das, R. K., et al., “3D-CT-Based High-Dose-Rate Breast Brachytherapy Implants: Treatment Planning and Quality Assurance”, Int. J. Radiation Oncology Biol. Phys. 2004, pp. 1224-1228, vol. 59, No. 4, Elsevier Inc.
Cuttino, L. W., et al., “CT-Guided Multi-Catheter Insertion Technique for Partial Breast Brachytherapy: Reliable Target Coverage and Dose Homogeneity”, Brachytherapy 4, 2005, pp. 10-17, Elsevier.
Glasgow, G. P., et al. “Remote Afterloading Technology”, AAPM Report No. 41, 1993, pp. i-vi and 1-107, American Institute of Physics, Inc.
Hoshino, T., “Brain Tumor Research Center”, Abstracts of the 11th Conference on Brain Tumor Research and Therapy, Journal of Neuro-Oncology 28, 1996, pp. 31-113.
Related Publications (1)
Number Date Country
20090198095 A1 Aug 2009 US
Provisional Applications (1)
Number Date Country
61062179 Jan 2008 US